Algernon Receives USPTO Allowance For Kidney Disease Patent
06 Jan 2025 //
GLOBENEWSWIRE
Algernon Receives Notice of Intention to Grant for Repirinast
31 Jan 2024 //
GLOBENEWSWIRE
Algernon Pharmaceuticals Receives Notice of Intention to Grant for Repirinast
30 Nov 2023 //
GLOBENEWSWIRE
Algernon Pharma Receives Japanese Patent Notice of Allowance for Repirinast
08 Nov 2023 //
GLOBENEWSWIRE
Algernon Provides Update on Planned PI Repirinast Chronic Kidney Disease Study
11 Jul 2022 //
GLOBENEWSWIRE
Algernon Pharmaceuticals Announces Lead Chronic Kidney Disease Drug Repirinast
26 Apr 2022 //
GLOBENEWSWIRE